Go Backs
HomeCategoriesStatesCheck Your Home
Go Backs

Track product recalls and safety alerts from CPSC, FDA, NHTSA, and USDA. Stay informed and keep your family safe.

Browse

  • Categories
  • States
  • Check Your Home
  • Risk Levels

Agencies

  • CPSC
  • FDA Food
  • FDA Drug
  • FDA Device
  • FDA Veterinary
  • NHTSA
  • USDA

Company

  • About
  • FAQ
  • Contact
  • Terms of Service
  • Privacy Policy
Buy Me a Coffee

Recall data is sourced from official U.S. government agencies (CPSC, FDA, NHTSA, USDA) and processed using AI to improve readability. This site is not affiliated with or endorsed by any government agency. Always refer to the original agency notice for authoritative information.

© 2026 Go Backs. All rights reserved.

Medium RiskFDA Device

Becton Dickinson & Company: Nonsterile syringe potentially exposing the patient to pathogenic microorganisms and a risk of local infection.

Agency Publication Date: March 10, 2023
Share:
Sign in to monitor this recall

Affected Products

Product: BD Ultra-Fine Insulin Syringe 0.5mL, 6mm, 31G - Insulin Syringes are designed for administering insulin in the treatment of diabetes mellitus. Catalog Number: 326679

UDI_DI: N/A Lot Number: 2164338 Exp Date: 20270831

Lot Numbers:
Number
Product: BD Insulin Syringes with the BD Micro-Fine TM IV Needle 1ml, 12.7mm, 28G Single Unit Scale. Insulin Syringes are designed for administering insulin in the treatment of diabetes mellitus. Catalog Number: 329420

GTIN: (01) 00382903294206 Lot Number: 2038204 Exp. Date: 20270430

Lot Numbers:
Number
Product: BD Insulin Syringes with the BD Micro-Fine IV Needle 1 ml, 12. 7mm, 28G Two Unit Scale- Insulin Syringes are designed for administering insulin in the treatment of diabetes mellitus. Catalog Number: 329424

GTIN : (01) 00382903294244 Lot Number: 2024074 Exp. Date: 2024074; Lot Number: 2045195 Exp. Date: 20270430

Lot Numbers:
Number
Number
Product: BD Ultra-Fine Insulin Syringe 0.5mL, 8mm, 31G-Insulin Syringes are designed for administering insulin in the treatment of diabetes mellitus. Catalog Number: 326713

GTIN: N/A Lot Number: 2038580, Exp. Date: 20270531; Lot Number: 2063298, Exp. Date: 20270531; Lot Number: 2137904, Exp. Date: 20270731

Lot Numbers:
Number
Number
Number
Product: BD Ultra-Fine Insulin Syringe 1mL, 6mm, 31G-Insulin Syringes are designed for administering insulin in the treatment of diabetes mellitus. Catalog Number: 326678

GTIN: N/A Lot Number: 2045201, Exp. Date: 20270430; Lot Number: 2073801, Exp. Date: 20270531

Lot Numbers:
Number
Number
Product: BD Insulin Syringes with the BD Micro-Fine IV Needle 0.5ml, 12.7mm, 28G Single Unit Scale-Insulin Syringes are designed for administering insulin in the treatment of diabetes mellitus. Catalog Number: 329461

GTIN: (01) 00382903294619 Lot Number: 2031528, Exp. Date: 20270430

Lot Numbers:
Number
Product: BD Ultra-Fine Insulin Syringe 1mL, 12.7mm, 29G-Insulin Syringes are designed for administering insulin in the treatment of diabetes mellitus. Catalog Number: 326719

GTIN: N/A Lot Number: 2031581, Exp. Date: 2031581

Lot Numbers:
Number
Product: BD Ultra-Fine II Insulin Syringe 0.5mL, 8mm, 30G-Insulin Syringes are designed for administering insulin in the treatment of diabetes mellitus. Catalog Number: 326725

GTIN: N/A Lot Number: 2010670, Exp. Date:2031581 Lot Number: 2052365, Exp. Date:20270531

Lot Numbers:
Number
Number

Additional Information

Agency: Food and Drug Administration (FDA)
Event ID: 91495
Status: Active
Manufacturer: Becton Dickinson & Company
Manufactured In: United States
Units Affected: 8 products (45, 000 units; 961,000 units; 1,921,000 units; 1,129,000 units; 1,168,000 units; 686,500 units; 80,500 units; 1,472,400 units)

Were You Affected by This Recall?

If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.

Find an Attorney

This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.

AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.

Sources: FDA iRES · Raw API Response

openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.